Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 Nov 2008 10:48

RNS Number : 4691I
British SmallerTechCompaniesVCT2PLC
19 November 2008
 

BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2008

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 30 September 2008. This constitutes the Company's second interim management statement for the financial year ending 31 December 2008, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

The unaudited net asset value per Ordinary share as at 30 September 2008 was 79.7 pence. This is a decrease of 3.9% over the net asset value of 82.9 pence per share at 30 June 2008.  The reduction is largely attributed to the recognition of the special and interim dividend paid to shareholders in September and totalling 4 pence per share. Hence the total return, calculated by reference to the net asset value plus cumulative dividends paid has increased from 94.9p per share at 30 June 2008 to 95.7 pence per share at 30 September 2008, an increase of 0.8%.  

In addition to the dividend, the last three months have seen the value of the AiM portfolio depressed given the market conditions and a £94k reduction in the portfolio has been recognised.  This represents a 6% reduction in the value of the AiM portfolio during the quarter. A review of the unquoted portfolio has identified some ups and downs, but minimal net impact on the value of the unquoted portfolio overall. The reduction in the value of the AiM portfolio has been offset by the recovery in the market value of the gilts, which have increased £110k during the period. At 30 September 2008, the Company held cash and Gilts representing 42.5% of the net asset value. 

This quarter has seen the inclusion of £164,000 in respect of the reclaim for irrecoverable VAT in line with the ruling by HMRC.

There has been no movement in the number of Ordinary shares, 16,641,257 Ordinary shares being in issue at both 31 December 2007 and 30 June 2008.

The Company has completed one investment in the quarter, being a £52,000 follow on equity investment in Manchester based computer chip designer Silistix Limited Disposals of £3,500 related to the scheduled loan repayments made by RMS Group Limited.

Net assets at 30 September 2008 comprised the following:

£000

% of net assets

Unquoted investments at fair value

5,815

43.8

Quoted investments at bid price

1,519

11.5

Total venture capital investments

7,334

55.3

Cash and cash equivalents

5,633

42.5

Other net current assets

295

2.2

Net assets

13,262

100.0

The net asset value per Ordinary share at 30 September 2008 was 79.7 pence. The net asset value remains significantly in excess of the current share price.

The ten largest investments by valuation at 30 September 2008 were as follows:

£000

% of net assets

Digital Healthcare

1,650

12.5

Immunobiology

850

6.4

Silistix

719

5.4

Primal Pictures

642

4.8

Pressure Technologies

520

3.9

ART

484

3.7

RMS

435

3.3

Cater Plus

345

2.6

DxS

320

2.4

Harvey Jones

278

2.1

Top ten investments

6,243

47.1

Other investments

1,091

8.2

Total venture capital investments

7,334

55.3

Quoted investments are carried at bid price at 30 September 2008. Unquoted investment are carried at fair value as at 30 September 2008 as determined by the directors.

During the three months ended 30 September 2008 the following significant investment transactions took place (all companies are unquoted except where otherwise indicated):

Follow-on Investments:

Name of company:

Business activity:

Amount invested £000

Silistix Ltd

Silicon chip design

52

52

In this period the Company has seen its underlying net asset value increase by 0.8 pence per share after the payment of an interim dividend of 2 pence per share and a special dividend of 2 pence share. It is pleasing to note that the residual net asset value has both increased and currently comprises 42.5% in gilts and cash.

With the principal investments in the portfolio all having secured funding with little exposure to financial leverage the portfolio is itself well placed to take advantage of expansion opportunities as they arise.

There has been a marked increase in the number of investment opportunities being presented. The Company's liquidity is good but your board will be seeking to increase this through a non-prospectus top up offer early in the New Year.

 

19 November 2008

For further information please contact:

David Hall YFM Private Equity Tel: 0161 832 7603

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGMCGUPRGUB
Date   Source Headline
11th Oct 20217:51 amRNSOffer Update
11th Oct 20217:49 amRNSOffer Update
7th Oct 20212:30 pmRNSInterim Dividend
28th Sep 20217:00 amRNSTransaction in Own Shares
27th Sep 20211:11 pmRNSOffer Update
27th Sep 20211:10 pmRNSOffer Update
24th Sep 202112:58 pmRNSOffer Update
24th Sep 202112:57 pmRNSOffer Update
22nd Sep 202112:00 pmRNSPublication of a Prospectus
22nd Sep 202112:00 pmRNSPublication of a Prospectus
10th Sep 20213:25 pmRNSHalf-year Report
27th Aug 20213:15 pmRNSStatement re Net Asset Value and Fundraising
25th Jun 20219:32 amRNSTransaction in Own Shares
15th Jun 20211:30 pmRNS1st Quarter Results
10th Jun 20211:25 pmRNSResult of AGM
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 20212:44 pmRNSAnnual Financial Report
11th Mar 20212:52 pmRNSDirector/PDMR Shareholding
11th Mar 20212:51 pmRNSIssue of Equity and Close of Offer
5th Mar 20219:14 amRNSPayment of dividend and issue of equity
3rd Mar 20219:55 amRNSClose of Offer to Further Applications
22nd Feb 20214:15 pmRNSUpdate on Offer
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
27th Jan 20218:42 amRNSDividend Declaration
15th Dec 202011:42 amRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNS3rd Quarter Results
28th Sep 20207:15 amRNSTransaction in Own Shares
28th Sep 20207:14 amRNSDirectorate Change
21st Sep 202010:03 amRNSPayment of Dividend and Issue of Equity
12th Aug 20202:02 pmRNSReplacement Half-year Report to 30 June 2020
12th Aug 202010:15 amRNSHalf-year Report to 30 June 2020
29th Jun 202011:53 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSInterim Management Statement
16th Jun 20203:52 pmRNSResult of Annual General Meeting
28th May 20208:25 amRNSAnnual General Meeting
12th May 202012:49 pmRNSPayment of Dividend (amended)
12th May 20209:00 amRNSPayment of Dividend
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSTransaction in Own Shares
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
20th Mar 20209:41 amRNSAnnual Financial Report
19th Dec 201910:17 amRNSTransaction in Own Shares
21st Nov 20191:00 pmRNSInterim Management Statement
27th Sep 20199:30 amRNSPurchase of Own Securities and Net Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.